Menu

Defining drug action at single cell resolution.

Allcyte

About Us

Allcyte is a biotech start-up company focused on diagnostics and drug activity profiling using next-generation microscopy to measure phenotypes at single cell resolution. Our web presence is still in the works, but feel free to contact us with questions.

The Team

Scientific founding team

Allcyte's founding team has a strong mix of immunology, computational biology and image analysis, chemistry, and biotech entrepreneurship. We also have close medical support from our partners at the Medical University of Vienna as well as other key collaborators in science and biotech development.

    Gregory Vladimer, PhD
    Co-Founder

Prof. Berend Snijder
Co-Founder

Prof. Giulio Superti-Furga
Co-Founder

Nikolaus Krall, PhD
Co-Founder

Press

  • Allcyte collaborates with Boehringer Ingelheim to advance preclinical oncology drug discovery by using novel drug response profiling technology

    On Septmeber 4th 2017, Allcyte announced a collaboration with Boehringer Ingelheim that will use our Pharmacoscopy high-throughput microscopy pipeline to profile the activity of selected Boehringer preclinical compounds at single cell resolution in primary patient material. Our novel technology promises to enable the matching of the best drug candidate to the best target indications, identification of candidate biomarkers, and the elucidation of the drug mechanism of action, which could shorten the time to the clinic. More information can be found in the press release .

Contact

Get In Touch.

Looking foward to hearing from you.

Send Us A Message
Sending...
Your message was sent, thank you!
Contact Information
Email Us At
office@allcyte.com
Call Us At
+43 676 9271943
Where to Find Us
Lazarettgasse 14
AKH 25.3
1090 Vienna, Austria